The European Union's Medical Device Regulation 2017/745 (EU MDR) came into
full application on May 26, 2021, replacing the Medical Device Directive
(MDD) that had governed medical device approvals since 1993. For
manufacturers of medical oxygen generators, the transition from MDD to MDR
represented more than a paperwork update - it fundamentally changed the
evidentiary burden required to place a medical device on the European
market.
This article provides a practical compliance overview for oxygen generator
manufacturers targeting EU market access. It assumes you understand the
basics of medical device regulation. What follows focuses on the specific
provisions most relevant to PSA, VPSA, and VSA oxygen generation systems.
Classification: Why Oxygen Generators Are Class IIb
Under EU MDR Annex VIII, medical oxygen generators are classified as Class
IIb devices. The classification rationale is straightforward: the device
supplies a gas that is administered to patients (Rule 11 of Annex VIII -
active devices intended to administer or exchange substances), and the gas
is delivered via a pipeline system that connects directly to patient
interfaces (ventilators, anesthesia machines, flowmeters).
Class IIb classification means your conformity assessment route requires
involvement of a Notified Body - you can't self-declare conformity. You
either follow Annex IX (quality management system audit) combined with
Annex XI (production quality assurance), or Annex X (type examination)
combined with Annex XI.
What's new under MDR vs MDD for oxygen generator manufacturers:
- More stringent clinical evaluation requirements (Annex XIV)
- Mandatory post-market surveillance (PMS) system with periodic safety
update reports (PSUR)
- Unique Device Identification (UDI) marking and registration in EUDAMED
database
- Enhanced requirements for the Person Responsible for Regulatory
Compliance (PRRC)
- Stricter rules on economic operators - importers and distributors now
share regulatory obligations
Technical Documentation: The Oxygen-Specific Sections
Annex II of the MDR details what your technical documentation must
contain. For oxygen generators, the following sections require particular
attention:
Device Description and Specification
Beyond listing components, you need to explain the principle of operation
clearly enough that a Notified Body reviewer can understand the full air
separation pathway: intake filtration, compression, drying/cooling,
molecular sieve adsorption, oxygen collection, purity monitoring, pipeline
delivery. Include process flow diagrams with instrumentation marked.
Specify the molecular sieve type (calcium, sodium, or lithium-based).
Design and Manufacturing Information
Provide design calculations for the adsorption tower sizing, cycle timing
optimization, and pressure vessel compliance where applicable. Note: VPSA
and VSA systems operating below 0.1 MPa typically fall below pressure
vessel thresholds. Include material specifications demonstrating oxygen
compatibility - all materials in contact with oxygen-enriched gas must
meet oxygen cleaning and compatibility standards (ISO 15001 or equivalent).
General Safety and Performance Requirements (GSPR)
Annex I of the MDR lists 23 GSPRs. For oxygen generators, pay special
attention to:
- GSPR 10 (substances): demonstrate that no oil or other contaminants
leach into the product gas from the compression process. Oil-free
compressor designs simplify this demonstration considerably.
- GSPR 11 (infection and microbial contamination): describe the
filtration and sterilization measures in the oxygen pathway.
- GSPR 14 (construction and interaction with environment): address fire
safety in oxygen-enriched environments.
- GSPR 17 (software): if your system includes intelligent control
software with automatic parameter adjustment, this software is a medical
device in its own right under MDR and must comply with IEC 62304.
Clinical Evaluation Under MDR
This is where many oxygen generator manufacturers struggle. Under MDD,
manufacturers could often demonstrate equivalence to existing devices and
rely on literature reviews. MDR tightens this substantially.
For oxygen generators, you'll need:
1. A systematic literature review demonstrating that 93 percent plus or
minus 3 percent oxygen generated by PSA/VPSA/VSA technology is clinically
safe and effective. Fortunately, this evidence base is robust - ISO 10083,
the US Pharmacopoeia (Oxygen 93 Percent), and the European Pharmacopoeia
all recognize this oxygen specification for medical use, with over 30
years of global clinical experience.
2. If claiming equivalence to an existing device, you need a contract with
the manufacturer of that device granting full access to their technical
documentation.
3. Post-market clinical follow-up (PMCF) data from your own installed
base. MDR expects you to proactively collect and analyze clinical data
from devices in use, not just wait for adverse event reports.
Post-Market Surveillance (PMS)
MDR Articles 83-86 establish PMS requirements that effectively turn every
installed oxygen generator into a data source. Your PMS system must
collect:
- Oxygen purity and output consistency data over time
- Unscheduled maintenance events and root cause analyses
- Customer complaints and their resolutions
- Any incidents involving patient harm or near-misses
For manufacturers with intelligent monitoring platforms (such as LBYL
Medical's IoT-based system), collecting this data is relatively
straightforward - the system already records performance parameters. For
manufacturers without remote monitoring, collecting PMS data requires a
more manual process.
Practical Steps Toward MDR Compliance
If you're a manufacturer currently targeting EU market access, here's the
prioritized action list:
1. Engage a Notified Body early. Don't wait until your technical
documentation is perfect. Start the conversation 12-18 months before you
need to be on the market.
2. Audit your clinical evidence gap. Most oxygen generator manufacturers
have strong preclinical testing data but relatively thin clinical
evaluation reports. The clinical evaluation is now the most common reason
for MDR certification delays.
3. Implement your PMS system before you need the data. Install remote
monitoring on existing systems now, not when the Notified Body asks for 2
years of surveillance data.
4. Get your UDI system in place. Register your devices in EUDAMED.
5. Review your economic operator agreements. Under MDR, your EU Authorized
Representative, importers, and distributors all carry regulatory
obligations.
MDR compliance for oxygen generators is demanding but achievable. The
manufacturers who navigate it successfully will find themselves in a
European market with higher barriers to entry - and consequently, less
price competition from manufacturers who can't or won't make the
investment.